Uncategorized
Bitcoin At A Crossroad: Why You Need To Watch $108,000 And $116,000
On-chain data shows that Bitcoin (CRYPTO: BTC) is holding a crucial support level at $114,000, with markets now at a crossroads that could define its next price direction. read more
Anglo Teck: A New Copper Empire Is Quietly Taking Shape
Anglo American’s tie-up with Teck could reshape the global commodities map. The merged company will have a strong focus on copper and generate significant savings and growth. Debt is low and dividends high. Latest Ratings for BHP Date Firm Action From To Jul 2021 Berenberg Upgrades Hold Buy Mar 2021 UBS Downgrades Buy Neutral Mar…
Oracle’s 40% Moonshot Put Defiance’s ORCX ETF On The Map
Defiance CEO Sylvia Jablonski on ORCX’s amplified Oracle rally, the risks of leverage, and why single-stock ETFs suit short-term AI trades. read more
Buffett, Ackman, Ives Are Now ETF Brands—And It’s Changing The Game
From Buffett’s OMAH to Ackman’s ACKY, the rise of personality ETFs is giving investors access to legendary strategies with unique twists. read more
Analysts Raise Price Targets Following Strong Data From Revolution Medicines’ Pancreatic Cancer Drug
Revolution Medicines reports positive results from daraxonrasib trials in metastatic pancreatic cancer, with strong response rates and consistent safety data. Latest Ratings for RVMD Date Firm Action From To Mar 2022 Stifel Upgrades Hold Buy Nov 2021 HC Wainwright & Co. Maintains Buy Sep 2021 Stifel Initiates Coverage On Hold View More Analyst Ratings for…
Who Wants To Be A Trillionaire? The Fed Chair Game Show
Trump’s search for a new Fed Chair raises concerns over central bank independence and long-term economic stability. read more
Maze Shares Jump As Investors Bet Big On Experimental Treatment’s Potential
Maze’s MZE782 showed strong Phase 1 results, supporting once- or twice-daily dosing with increased amino acid excretion and no serious side effects. read more